Dechert advised MiddleGround Capital, while Ropes & Gray served as legal counsel to Starrett on the deal. MiddleGround Capital, a private equity firm, announced their definitive...
MiddleGround Capital’s Acquisition of The L.S. Starrett Company
LianBio’s License Agreement with Bristol Myers Squibb
Ropes & Gray represented LianBio on the deal. LianBio (Nasdaq: LIAN) announced it has entered into an agreement with Bristol Myers Squibb (NYSE:BMY)(BMS), whereby BMS has obtained...
Eli Lilly’s Acquisition of Sigilon Therapeutics
Morgan, Lewis & Bockius acted as legal counsel to Eli Lilly, and Ropes & Gray acted as legal counsel to Sigilon. Eli Lilly and Company (NYSE:...
BP’s $1.3 Billion Acquisition of TravelCenters of America
Jones Day advised Citigroup on the deal while Ropes & Gray advised TravelCenters of America Inc. (TA). TravelCenters of America Inc. (Nasdaq: TA), the nationwide operator...
GI Partners’ $1.05 Billion Acquisition of Atlas Technical Consultants
Ropes & Gray LLP advised GI Partners, and Kirkland & Ellis LLP and Potter Anderson & Corroon LLP advised Atlas on the deal. Latham & Watkins...
Rallybio’s $50 Million Common Stock Offering
Ropes & Gray represented Rallybio, while Latham & Watkins represented the underwriters in the offering. Rallybio Corporation (Rallybio) (Nasdaq: RLYB), a clinical-stage biotechnology company, has announced...
Blackstone’s $1 Billion Financing Collaboration with PTC Therapeutics
WilmerHale advised PTC Therapeutics, while Ropes & Gray advised Blackstone on the deal. Blackstone announced a strategic financing collaboration for up to $1 billion in funding...
Patient Square Capital and Gurnet Point Capital’s $890 Million Acquisition of Radius Health
Kirkland & Ellis advised Patient Square Capital, Ropes & Gray advised Radius, Latham & Watkins advised Gurnet Point Capital, Covington & Burling served as OrbiMed’s legal...
Taro Pharmaceutical Industries’ Acquisition of Alchemee
Cravath and Lenz & Staehelin represented Taro in connection with the transaction. Ropes & Gray advised Galderma. Taro Pharmaceutical Industries Ltd. (“Taro”), a multinational, science-based pharmaceutical...
U.S. AutoForce’s Acquisition of Max Finkelstein
Ropes & Gray advised Max Finkelstein Inc. in the transaction. Max Finkelstein Inc. executed its sale to U.S. AutoForce and will operate as a division of...
Galderma’s Acquisition of Alastin Skincare
Ropes & Gray advised Galderma on the deal, while Latham & Watkins advised ALASTIN. Galderma, one of the world’s largest independent dermatology companies, executed its acquisition...
Pfizer’s Collaboration With Biohaven Pharmaceutical Company
Ropes & Gray represented Pfizer in the deal. Pfizer announced its collaboration arrangement with Biohaven Pharmaceutical Company to commercialize rimegepant, a therapy approved in the U.S. as...